Biomark Diagnostics Inc. (FRA:20B)
0.366
+0.002 (0.55%)
Last updated: Mar 9, 2026, 8:10 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €38.46 million as of March 9, 2026. Its market cap has increased by 225.54% in one year.
Market Cap
38.46M
Enterprise Value
38.11M
Revenue
57.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.37
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 38.46M, an increase of 34.98%. That is a compound annual growth rate of 2.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 38.40M |
| OTRS AG | 36.22M |
| Fair Value REIT-AG | 40.96M |
| U.C.A. Aktiengesellschaft | 35.53M |
| edding AG | 35.48M |
| SBF AG | 42.90M |
| Enapter AG | 43.39M |
| Fernheizwerk Neukölln Aktiengesellschaft | 45.77M |